DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 0.5%
March 26, 2019 09:24 AM

DIVIS LABORATORIES share price has hit an all-time high at Rs 1,767 (up 1.5%).

Meanwhile, the BSE HEALTHCARE Index is at 14,189 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 1.5%) and ABBOTT INDIA (up 0.5%).

APOLLO HOSPITALS and DR. LAL PATHLABS LTD (down 0.1%) are among the top losers today.

Over the last one year, DIVIS LABORATORIES has moved up from Rs 1,057 to Rs 1,767, registering a gain of Rs 710 (up 63.9%).

The BSE HEALTHCARE has moved up from 13,186 to 14,189, registering a gain of 1,003 points (up 7.5%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 63.9%), SUVEN LIFESCIENCES (up 55.0%) and PFIZER (up 51.4%).

What About the Benchmark Indices?

The BSE Sensex is at 37,910 (up 0.2%). The top gainers among the BSE Sensex stocks today are NTPC (up 1.9%), COAL INDIA (up 1.7%) and VEDANTA LTD (up 1.3%). Other gainers include ONGC (up 1.2%) and BHARTI AIRTEL (up 0.9%). The most traded stocks in the BSE Sensex are NTPC and COAL INDIA.

In the meantime, NSE Nifty is at 11,393 (up 0.2%). The top gainers in the NSE Nifty include IOC (up 2.9%), ONGC (up 2.1%) and COAL INDIA (up 1.9%). Other gainers include NTPC (up 1.7%) and HPCL (up 1.7%).

Over the last 12 months, the BSE Sensex has moved up from 33,066 to 37,910, registering a gain of 4,844 points (up 14.6%).

DIVIS LABORATORIES Financial Update...

DIVIS LABORATORIES net profit stood at Rs 4 billion for the quarter ended December 2018, compared to a profit of Rs 2 billion a year ago. Net Sales rose 29.4% to Rs 13.4 billion during the period as against Rs 10.4 billion in October-December 2017.

For the year ended March 2018, DIVIS LABORATORIES reported 17.3% decrease in net profit to Rs 8.8 billion compared to net profit of Rs 10.6 billion during FY17.

Revenue of the company grew 4.7% to Rs 39 billion during FY18.

The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 35.3x.